Homocyst(e)ine, Diet, and Cardiovascular Diseases
نویسندگان
چکیده
منابع مشابه
Homocysteine and cardiovascular diseases.
To the Editor: Malinow et al,1 in their recent review on homocysteine and cardiovascular diseases, correctly state that based on the available evidence, it is premature to conclude that total homocysteine (tHcy) plasma levels are predictive of the development of cardiovascular events. Their conclusion is mostly based on the analysis of the results of prospective cohort studies of tHcy in cardio...
متن کاملNutrigenomics, cardiovascular diseases and the Mediterranean diet
Article available on line / Article disponible en ligne à l’adresse : -------------------------------------------------------------------------------------------------------------------------------------------------------------------------http://om.ciheam.org/article.php?IDPDF=6813 ------------------------------------------------------------------------------------------------------------------...
متن کاملMolecular and Biochemical Aspects of Homocysteine in Cardiovascular Diseases
Homocysteine also known as the H-factor, is a naturally occurring amino acid and is a by-product of methionine metabolism in the body. It is a common amino acid (one of the building blocks that make up proteins) found in the blood and is acquired mostly from eating meat. In 1969, a connection between homocysteine (a sulfur-containing amino acid) and cardiovascular disease was proposed when it w...
متن کاملHomocysteine and cardiovascular disease.
An elevated level of total homocysteine (tHcy) in blood, denoted hyperhomocysteinemia, is emerging as a prevalent and strong risk factor for atherosclerotic vascular disease in the coronary, cerebral, and peripheral vessels, and for arterial and venous thromboembolism. The basis for these conclusions is data from about 80 clinical and epidemiological studies including more than 10,000 patients....
متن کاملHomocysteine and Cardiovascular Risk
Several scoring systems, based on traditional risk factors, are available for the 10-year quantification of cardiovascular (CV) risk for either coronary heart disease (CHD) or cardiovascular disease (CVD) events. Assessing CV risk is useful to identify patients requiring aggressive management (i.e., high risk) or monitoring (i.e., low risk) or those at intermediate risk. The last group presents...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 1999
ISSN: 0009-7322,1524-4539
DOI: 10.1161/01.cir.99.1.178